2.15

1.65% 0.035

Creative Medical Technology Holdings Inc (CELZ)

Überblick Nachrichten Preisverlauf Financials Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$2.115

Offen:

$2.16

24-Stunden-Volumen:

72,589

Relative Volume:

0.74

Marktkapitalisierung:

$7.51M

Einnahmen:

$102.80K

Nettoeinkommen (Verlust:

$-5.32M

KGV:

-0.5658

EPS:

-3.8

Netto-Cashflow:

$-5.45M

1W Leistung:

-2.71%

1M Leistung:

-29.51%

6M Leistung:

-14.00%

1J Leistung:

-1.83%

1-Tages-Spanne:

$2.04

$2.26

1-Wochen-Bereich:

$2.0284

$2.33

52-Wochen-Spanne:

$1.69

$6.90

Creative Medical Technology Holdings Inc Stock (CELZ) Company Profile

Firmenname

Creative Medical Technology Holdings Inc

Sektor

Healthcare (1136)

Branche

Biotechnology (632)

Telefon

480-399-2822

Adresse

211 E. OSBORN RD., PHOENIX

Mitarbeiter

Twitter

Nächster Verdiensttermin

2024-11-12

Neueste SEC-Einreichungen

CELZ's Discussions on Twitter

Vergleichen Sie CELZ mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
CELZ Creative Medical Technology Holdings Inc	2.15	7.39M	102.80K	-5.32M	-5.45M	-3.80
VRTX Vertex Pharmaceuticals Inc	446.09	114.05B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	747.49	78.80B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	396.08	51.80B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	850.56	53.08B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	164.41	42.33B	447.02M	-1.18B	-906.14M	-6.1812

Creative Medical Technology Holdings Inc Aktie (CELZ) Neueste Nachrichten

03:57 AM

What risks investors should watch in Creative Medical Technology Holdings Inc. stockDollar Strength & Weekly Top Stock Performers List - Улправда

03:57 AM

03:53 AM

Creative Medical Wraps Up ADAPT Trial Enrollment For Chronic Lower Back Pain - Nasdaq

03:53 AM

03:20 AM

Will Creative Medical Technology Holdings Inc. stock see insider buyingWeekly Investment Report & Safe Capital Investment Plans - Улправда

03:20 AM

Dec 17, 2025

Creative Medical completes enrollment in chronic back pain trial By Investing.com - Investing.com Canada

Dec 17, 2025

Creative Medical Technology Holdings, Inc. Completes Enrollment in FDA-Cleared Adapt Trial for CELZ-201-Olastrocel, Marking Major Clinical Inflection Point - marketscreener.com

Dec 17, 2025

Digicontent Limited (542685) Stock RalliesJuly 2025 EndofMonth & Growth Focused Entry Point Reports - Bollywood Helpline

Dec 17, 2025

Creative Medical Technology completes enrollment in FDA-cleared Adapt trial - marketscreener.com

Dec 17, 2025

Longeveron Granted U.S. Patent for Method of Treating Female Sexual Dysfunction Using its Proprietary Stem Cell Therapy - The Manila Times

Dec 17, 2025

Inspirato Announces Agreement to be Acquired by Exclusive Investments LLC - The Manila Times

Dec 17, 2025

SafeSpace Global Corporation (OTCID: SSGC) Appoints Harvest Communications as Investor Relations and Corporate Communications Consulting Agency - The Manila Times

Dec 17, 2025

Creative Medical Technology Holdings, Inc. Completes Enrollment in FDA-Cleared ADAPT Trial for CELZ-201-Olastrocel, Marking Major Clinical Inflection Point - The Manila Times

Dec 17, 2025

Retell AI, Fastest-Growing AI Voice Agent Platform, Launches First Automated QA Solution to Accelerate Enterprise Adoption of Voice AI - The Manila Times

Dec 17, 2025

New cell therapy for chronic back pain reaches key milestone in clinical test - Stock Titan

Dec 17, 2025

Kretto Syscon Limited Recovery Linked to Earnings SurpriseStock Watchlist Updates & High Return Market Tips - Bollywood Helpline

Dec 17, 2025

Dec 16, 2025

Shiv Texchem Limited Stock Lags Behind Sector BenchmarksTrade Execution Strategies & Free Unlock Stock Analysis - Bollywood Helpline

Dec 16, 2025

Resistance Break Could Fuel Diligent Media Corporation Limited RallyCup and Handle Formations & Budget Friendly Portfolio Growth - Bollywood Helpline

Dec 16, 2025

Dec 12, 2025

Market Moves: Will Creative Medical Technology Holdings Inc. stock deliver better than expected guidance2025 Major Catalysts & AI Powered Trade Plan Recommendations - moha.gov.vn

Dec 12, 2025

Dec 06, 2025

Creative Medical Technology (NASDAQ:CELZ) Upgraded by Wall Street Zen to “Hold” Rating - Defense World

Dec 06, 2025

Dec 03, 2025

Is Creative Medical Technology Holdings Inc. stock a safe buy before earnings - Newser

Dec 03, 2025

Dec 02, 2025

WHO approves olastrocel as international name for CELZ-201 therapy By Investing.com - Investing.com Nigeria

Dec 02, 2025

Creative Medical Technology Holdings Announces World Health Organization Approval of "Olastrocel" as Inn for Lead Allogeneic Cell Therapy Celz-201 - marketscreener.com

Dec 02, 2025

Creative Medical (CELZ) Gains WHO Approval for Key Therapy Compo - GuruFocus

Dec 02, 2025

WHO approves olastrocel as international name for CELZ-201 therapy - Investing.com

Dec 02, 2025

Creative Medical Technology Holdings announces World Health Organization approval of "Olastrocel" - marketscreener.com

Dec 02, 2025

Creative Medical Technology Holdings Announces World Health Organization Approval of 'olastrocel” as INN for Lead Allogeneic Cell Therapy CELZ-201 - The Manila Times

Dec 02, 2025

Creative Medical (NASDAQ: CELZ) gets WHO INN 'olastrocel' for CELZ-201 cell therapy - Stock Titan

Dec 02, 2025

Dec 01, 2025

Creative Planning Acquires 4,480 Shares of Teleflex Incorporated $TFX - MarketBeat

Dec 01, 2025

Nov 30, 2025

SS&C Technologies Holdings, Inc. $SSNC Shares Purchased by Creative Planning - MarketBeat

Nov 30, 2025

Nov 29, 2025

Creative Planning Boosts Holdings in Charles River Laboratories International, Inc. $CRL - Defense World

Nov 29, 2025

Nov 28, 2025

Creative Planning Has $1.82 Million Stake in Akamai Technologies, Inc. $AKAM - MarketBeat

Nov 28, 2025

Creative Planning Has $1.90 Million Stock Holdings in Glaukos Corporation $GKOS - MarketBeat

Nov 28, 2025

Nov 27, 2025